Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment In Vitro

Cells(2024)10.3390/cells13040351Source: DataRank Database

The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment In Vitro is a research paper published in Cells (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.93)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Daniel J. Patton,Isabella M. Shimko-Lofano,Timothy L. Eller,Roberto Molinari ORCID,Maninder Sandey ORCID

Live enrichment

PubMed:38391964 PMC:PMC10886739 OpenAlex:https://openalex.org/W4391942626

Office of Research and Graduate Studies (ORGS)

Grant: R15-CA283777-01

NCI NIH HHS

Grant: R15 CA283777

NCI NIH HHS

Grant: R15 CA277677

Office of Research and Graduate Studies

Scott Ritchey Research Center

FWCI

1.93

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3390/cells13040351

publisherhttps://doi.org/10.3390/cells13040351

publisherhttps://www.mdpi.com/2073-4409/13/4/351/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38391964

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10886739

Fields of Study

Virus-based gene therapy researchCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in InsectsMedicineBiology

MeSH Terms

Bone NeoplasmsHumansOsteosarcomaOncolytic VirotherapyOncolytic VirusesTumor MicroenvironmentSingle-Domain Antibodies

Keywords

Oncolytic virusOsteosarcomaCancer researchImmune systemTumor microenvironmentIn vitroCell cultureVirologyMedicineBiologyImmunologyPD-L1PD-1Cancer Immunotherapyoncolytic adenovirusImmune Checkpoint InhibitorConditionally Replicative Adenovirus (Crad)

Sustainable Development Goals

SDG 0: Good health and well-being

The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment In Vitro

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)